Mendelian Randomization Analysis of the Relationship Between Native American Ancestry and Gallbladder Cancer Risk
Linda Zollner,Felix Boekstegers,Carol Barahona Ponce,Dominique Scherer,Katherine Marcelain,Valentina Gárate-Calderón,Melanie Waldenberger,Erik Morales,Armando Rojas,César Munoz,Bettina Müller,Javier Retamales,Gonzalo de Toro,Allan Vera Kortmann,Olga Barajas,María Teresa Rivera,Analía Cortés,Denisse Loader,Javiera Saavedra,Lorena Gutiérrez,Alejandro Ortega,Maria Enriqueta Bertrán,Leonardo Bartolotti,Fernando Gabler,Mónica Campos,Juan Alvarado,Fabricio Moisán,Loreto Spencer,Bruno Nervi,Daniel Carvajal,Héctor Losada,Mauricio Almau,Plinio Fernández,Jordi Olloquequi,Alice R. Carter,Juan Francisco Miquel Poblete,Bernabe Ignacio Bustos,Macarena Fuentes Guajardo,Rolando Gonzalez-Jose,Maria Cátira Bortolini,Victor Acuña-Alonzo,Carla Gallo,Andres Ruiz Linares,Francisco Rothhammer,Justo Lorenzo Bermejo
DOI: https://doi.org/10.1101/2022.05.03.22274595
2022-01-01
Abstract:Background A strong association between the proportion of Native American ancestry and the risk of gallbladder cancer (GBC) has been reported in observational studies. Chileans show the highest incidence of GBC worldwide, and the Mapuche are the largest Native American people in Chile. We set out to investigate the causal association between Native American Mapuche ancestry and GBC risk, and the possible mediating effects of gallstone disease and body mass index (BMI) on this association.
Methods Markers of Mapuche ancestry were selected based on the informativeness for assignment measure and then used as instrumental variables in two-sample mendelian randomization (MR) analyses and complementary sensitivity analyses.
Result We found evidence of a causal effect of Mapuche ancestry on GBC risk (inverse variance-weighted (IVW) risk increase of 0.8% for every 1% increase in Mapuche ancestry proportion, 95% CI 0.4% to 1.2%, p = 6.6×10-5). Mapuche ancestry was also causally linked to gallstone disease (IVW risk increase of 3.6% per 1% increase in Mapuche proportion, 95% CI 3.1% to 4.0%, p = 1.0×10-59), suggesting a mediating effect of gallstones in the relationship between Mapuche ancestry and GBC. In contrast, the proportion of Mapuche ancestry showed a negative causal effect on BMI (IVW estimate -0.006 kg/m2 per 1% increase in Mapuche proportion, 95% CI -0.009 to -0.003, p = 4.4×10-5).
Conclusions The results presented here may have significant implications for GBC prevention and are important for future admixture mapping studies. Given that the association between Mapuche ancestry and GBC risk previously noted in observational studies appears to be causal, primary and secondary prevention strategies that take into account the individual proportion of Mapuche ancestry could be particularly efficient.
### Competing Interest Statement
The authors have declared no competing interest.
### Funding Statement
This study was supported by the European Union’s Horizon 2020 research and innovation program (grant 825741, JLB, <https://ec.europa.eu/info/research-and-innovation/funding/funding-opportunities/funding-programmes-and-open-calls/horizon-2020_en>) and the Deutsche Forschungsgemeinschaft (DFG grant LO 1928/11-1, project number 424112940, JLB, <https://www.dfg.de/en/research_funding/index.html>). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
### Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the ethics committees of Servicio de Salud Metropolitano Oriente, Santiago de Chile (#06.10.2015, #08.03.2016 and #12.11.2019), Servicio de Salud Metropolitano Sur Oriente, Santiago de Chile (#15.10.2015 and #05.04.2018), Servicio de Salud Metropolitano Central, Santiago de Chile (#1188-2015), Servicio de Salud Coquimbo, Coquimbo, Chile (#01.04.2016), Servicio de Salud Maule, Talca, Chile (#05.11.2015), Universidad Cat#x00F3;lica del Maule, Talca, Chile (#102-2020), Servicio de Salud Concepción, Concepción, Chile (ID: 16-11-97 and ID:19-12-111), Servicio de Salud Araucanía Sur, Temuco, Chile (#10.02.2020), Servicio de Salud Valdivia, Valdivia, Chile (ID:438), Centro de Bioética, Universidad del Desarrollo, Cl#x00ED;nica Alemana de Santiago, Santiago de Chile (#2018-97, ID 678) and Unidad de Investigación Hospital San Juan de Dios, Santiago de Chile (#6182), the Medical Faculties of Universidad de Chile (approval #123-2012 and #11.10.2012) and Pontificia Universidad Cat#x00F3;lica de Chile (#11-159), and Universidad de Tarapacá and University College London as described in ([Ruiz-Linares et al., 2014][1]). All participants provided written informed consent before enrolment.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
The source code to reproduce all the results described is provided as supplementary material, and the necessary input files are available at [www.biometrie.uni-heidelberg.de/StatisticalGenetics/Software\_and\_Data][2].
[www.biometrie.uni-heidelberg.de/StatisticalGenetics/Software\_and\_Data][2]
[1]: #ref-27
[2]: http://www.biometrie.uni-heidelberg.de/StatisticalGenetics/Software_and_Data